French manufacturer: EMA is checking approval of the Corona

The European Medicines Agency (EMA) has started examining the approval of the corona vaccine from the French manufacturer Sanofi.

"EMA will assess the compliance of Vidprevtyn with the usual EU standards for efficacy, safety and quality," said the Amsterdam-based authority on Tuesday.

Sanofi developed Vidprevtyn together with the British company GSK.

Unlike the mRNA vaccines from BioNTech and Moderna, the product does not require extremely low temperatures during storage, which would make delivery logistically easier.

Like most corona vaccines, two doses are needed for comprehensive protection.

The decision to start a so-called rolling review is based on preliminary results, which "indicate that the vaccine triggers the production of antibodies that (...) can help protect against the disease," said the EMA.

They will evaluate further data "as soon as they are available in order to decide whether the benefits outweigh the risks".

She did not give a more precise schedule. 

The vaccines from BioNTech / Pfizer, Moderna, AstraZeneca and Johnson & Johnson are now approved in the EU. The Russian remedy Sputnik V and the Chinese vaccine Sinovac are also still being examined.